Infectious diseases are expected in wearable shipping captured by 27M this year

• Manufacturers are expected to ship 27 million fewer wearable devices than expected this year as the company says consumers make less essential purchases and supply chains weaken due to the COVID-19 pandemic.

• Researchers now expect a total of 254 million wearable devices to be shipped in 2020, up from 281 million previously forecast. This represents a decrease of almost 10%, although this is still a slight increase from the volume of 241 million shipments in 2019.

• Analysts predict a sustained recovery for the industry as wearable devices strengthen their advanced health monitoring capabilities and consumers become increasingly health-conscious. This leads the wearable device market in the second half of 2020 and paves the way for 289 million deliveries of wearable devices in 2021.

The pandemic is squeezing the wearable device market as consumers close their pockets on nonessential items to deal with the economic impact. However, the novel coronavirus has accelerated the shift to digital care, and increased patient adoption of telemedicine and virtual support strategies such as remote monitoring of patients, for example, could be a definite benefit for patients. Manufacturers of portable devices.

The researchers now identify the year-over-year increase in wearable device shipments from 2019 to 2020 to 5% versus the previously forecast 17%. This corresponds to a growth of 23% compared to the previous year between 2018 and 2019.

“While wearable devices ship fewer than originally expected this year, shipments of devices capable of tracking and monitoring health care vital signs have reduced the impact,” said Stephanie Tomsett, research analyst at ABI, in a notice that has been used to monitor the progression of COVID-19 and monitor patients remotely at home.

A slight increase in demand is expected for all wearable devices, not just health-oriented devices, in the second half of the year, especially for smartwatches and fitness and wellness trackers. However, devices with health monitoring capabilities are expected to perform at their best as the pandemic continues to raise medical awareness and consumers look for ways to monitor their health in the context of the new normal.

Wearable players conduct a series of studies to test the effectiveness of their devices in a race for unique health traits. While smartwatches and other tools struggle with the accuracy of devices, use cases, and patient demographics, there is little evidence that trackers are actually helping consumers achieve their goals. Health has not hindered acceptance. Almost a fifth of Americans says they own a smartwatch.

The big manufacturers Apple, Fitbit, and Samsung already offer or are developing health functions such as EKG monitoring, sleep apnea detection, arrhythmia warning messages, blood oxygen monitoring, menstrual cycle monitoring, and much more.

Manufacturers are also exploring possible wider public health applications. The 13-year-old Fitbit is working with Scripps Research and Stanford Medicine to investigate the role his devices could play in the early detection of infectious diseases such as the coronavirus before the actual symptoms appear. A study published in The Lancet in January suggested that widespread use of Fitbit devices could be used to track flu outbreaks and the spread of disease.

Fitbit, which received emergency support from the FDA on Monday for fresh air for COVID-19 patients, accepted a $ 2.1 purchase offer from Google. Last year. The merchants are US investigators. Department of Justice and other regulators as Google would provide a ton of consumer information that has an uneven track record when it comes to data confidentiality.